N04.B1

Clinical Causes: The precise cause of IC-MPGN remains unknown (idiopathic), but it involves immune system abnormalities. Immune complexes, which are groups of immune system proteins and other substances, deposit in the glomeruli and trigger inflammation. Potential environmental triggers or genetic factors may influence disease development, though specific causes are not established.

Key Symptoms: Swelling in the ankles, legs, or around the eyes (edema) Foamy or frothy urine due to high protein content (proteinuria) Weight gain from fluid retention Fatigue and tiredness Reduced urination or dark-colored urine High blood pressure (hypertension) Elevated levels of cholesterol and triglycerides in the blood

Diagnosis Path: Urine tests to detect high levels of protein (proteinuria) Blood tests to assess kidney function and look for signs of inflammation Kidney biopsy to examine tissue samples for characteristic changes associated with IC-MPGN Imaging studies such as ultrasound to evaluate kidney size and structure

Treatment Protocols: Immunosuppressive medications to reduce immune system activity and inflammation Corticosteroids to decrease inflammation and immune response Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to control blood pressure and decrease protein loss Diuretics to help reduce swelling and excess fluid retention Dietary modifications, including reduced salt intake and limit of protein in some cases Regular monitoring of kidney function and symptoms to adjust treatment plans accordingly In severe cases, other therapies like plasma exchange or additional immunosuppressive agents may be considered